These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10577972)

  • 21. Interleukin-18 promotes joint inflammation and induces interleukin-1-driven cartilage destruction.
    Joosten LA; Smeets RL; Koenders MI; van den Bersselaar LA; Helsen MM; Oppers-Walgreen B; Lubberts E; Iwakura Y; van de Loo FA; van den Berg WB
    Am J Pathol; 2004 Sep; 165(3):959-67. PubMed ID: 15331419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction.
    Lubberts E; Joosten LA; van Den Bersselaar L; Helsen MM; Bakker AC; van Meurs JB; Graham FL; Richards CD; van Den Berg WB
    J Immunol; 1999 Oct; 163(8):4546-56. PubMed ID: 10510398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined inhibition of tumor necrosis factor α and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody.
    Fischer JA; Hueber AJ; Wilson S; Galm M; Baum W; Kitson C; Auer J; Lorenz SH; Moelleken J; Bader M; Tissot AC; Tan SL; Seeber S; Schett G
    Arthritis Rheumatol; 2015 Jan; 67(1):51-62. PubMed ID: 25303306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice.
    Van Lent PL; Van De Loo FA; Holthuysen AE; Van Den Bersselaar LA; Vermeer H; Van Den Berg WB
    J Rheumatol; 1995 Dec; 22(12):2250-8. PubMed ID: 8835558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation.
    Hayer S; Bauer G; Willburger M; Sinn K; Alasti F; Plasenzotti R; Shvets T; Niederreiter B; Aschauer C; Steiner G; Podesser BK; Smolen JS; Redlich K
    Dis Model Mech; 2016 Nov; 9(11):1329-1338. PubMed ID: 27638666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
    Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
    Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.
    Koenders MI; Kolls JK; Oppers-Walgreen B; van den Bersselaar L; Joosten LA; Schurr JR; Schwarzenberger P; van den Berg WB; Lubberts E
    Arthritis Rheum; 2005 Oct; 52(10):3239-47. PubMed ID: 16200598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of TNFalpha-antagonists on nitric oxide production in human cartilage.
    Vuolteenaho K; Moilanen T; Hämäläinen M; Moilanen E
    Osteoarthritis Cartilage; 2002 Apr; 10(4):327-32. PubMed ID: 11950256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation.
    van de Loo FA; Arntz OJ; van Enckevort FH; van Lent PL; van den Berg WB
    Arthritis Rheum; 1998 Apr; 41(4):634-46. PubMed ID: 9550472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scavenger receptor class A type I/II determines matrix metalloproteinase-mediated cartilage destruction and chondrocyte death in antigen-induced arthritis.
    van Lent PL; Hofkens W; Blom AB; Grevers L; Sloetjes A; Takahashi N; van Tits LJ; Vogl T; Roth J; de Winther MP; van den Berg WB
    Arthritis Rheum; 2009 Oct; 60(10):2954-65. PubMed ID: 19790077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
    Liu Q; Zhao J; Tan R; Zhou H; Lin Z; Zheng M; Romas E; Xu J; Sims NA
    Scand J Rheumatol; 2015 May; 44(3):182-91. PubMed ID: 25439190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis.
    Mori T; Miyamoto T; Yoshida H; Asakawa M; Kawasumi M; Kobayashi T; Morioka H; Chiba K; Toyama Y; Yoshimura A
    Int Immunol; 2011 Nov; 23(11):701-12. PubMed ID: 21937456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE; van de Loo FA; Walgreen B; Bennink M; Helsen M; van den Bersselaar L; Wicks IP; van den Berg WB; Koenders MI
    Arthritis Res Ther; 2015 Jun; 17(1):163. PubMed ID: 26081345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local effects of intra-articular injection of anti-rabbit tumor necrosis factor alpha monoclonal antibody in antigen-induced arthritis of the rabbit temporomandibular joint.
    Ohtani T; Habu M; Khanal A; Yoshioka I; Matsukawa A; Tominaga K
    J Oral Pathol Med; 2012 Jan; 41(1):96-105. PubMed ID: 22004078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis.
    van de Loo FA; Arntz OJ; Otterness IG; van den Berg WB
    J Rheumatol; 1992 Mar; 19(3):348-56. PubMed ID: 1578447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncoupling of inflammatory and destructive mechanisms in arthritis.
    van den Berg WB
    Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):7-16. PubMed ID: 11357166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GM-CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice.
    Plater-Zyberk C; Joosten LA; Helsen MM; Hepp J; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2007 Apr; 66(4):452-7. PubMed ID: 17020908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proinflammatory cytokine interleukin-17 and its role in pathogenesis of rheumatoid arthritis].
    Leonaviciene L; Bradūnaite R; Astrauskas V
    Medicina (Kaunas); 2004; 40(5):419-22. PubMed ID: 15170409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone destruction in arthritis.
    Gravallese EM
    Ann Rheum Dis; 2002 Nov; 61 Suppl 2(Suppl 2):ii84-6. PubMed ID: 12379632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.